The two companies will explore technologies, including AI, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management.
The AI-enabled Watson virtual agent can help enable greater access to accurate and helpful information about benefits and healthcare costs.
Watson cognitive tech will be integrated into the MAP Recovery Network Platform to enhance the platform's existing capabilities.
Initially, IBM Watson Health's Imaging group will distribute the MedyMatch brain bleed detection app globally through its vendor neutral sales channels.
Together with Big Blue, the charity aims to provide people seeking help with access to personalized information from the Arthritis Research UK website.
The company has also launched Watson Health Consulting Services unit to help clients transform healthcare by leveraging the power of cognitive solutions.
The two parties will explore the exchange of data from several sources, such as EMRs, clinical trials, genomic data, and health data from mobile devices.
This AI app could be focused in the area of healthcare, but could also be aimed at education, energy, environment, global development or exploration.
The initiative is comprised of more than 15 leading health systems, academic medical centers, ambulatory radiology providers and imaging technology companies.
The app will help surgeons streamline their workflow by delivering patient information and clinical insights, as well as intraocular lens (IOL) options.